Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Hull and East Yorkshire Hospitals NHS Trust North of England Medical & Hyperbaric Services |
---|---|
Information provided by: | Hull and East Yorkshire Hospitals NHS Trust |
ClinicalTrials.gov Identifier: | NCT00623142 |
The purpose of this study was to determine if treating patients who have coronary heart disease with hyperbaric oxygen (HBO) prior to coronary artery bypass graft (CABG) surgery reduces injury to the heart and vascular system during and after surgery. Furthermore, this study also aims to identify some of the post CABG clinical effects of HBO treatment prior to CABG.
Condition | Intervention | Phase |
---|---|---|
Myocardial Reperfusion Injury Cytoprotection |
Drug: Hyperbaric Oxygen |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Health Services Research, Randomized, Single Blind (Caregiver), Parallel Assignment, Safety/Efficacy Study |
Official Title: | The Effects of Hyperbaric Oxygen Preconditioning On Cardiovascular Protection & Ischemic Reperfusion Injury |
Enrollment: | 81 |
Study Start Date: | January 2005 |
Study Completion Date: | January 2008 |
Primary Completion Date: | January 2007 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: No Intervention
Patients in this arm were not treated with HBO prior to CABG
|
|
B: Experimental
Patients in this arm were treated with HBO prior to CABG
|
Drug: Hyperbaric Oxygen
100% Oxygen at 2.4 ATA for 30 minutes followed by 5 minutes break followed by 100% Oxygen at 2.4 ATA for another 30 minutes. This intervention was given about 4 to 5 hours prior to CABG
|
Ages Eligible for Study: | 20 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United Kingdom, East Riding of Yorkshire | |
Hull & East Yorkshire NHS Trust (Castle Hill Hospital) | |
Hull, East Riding of Yorkshire, United Kingdom, HU16 5JQ |
Principal Investigator: | Jeysen Z Yogaratnam, MB.BCh, BAO, MRCS | Hull & East Yorkshire NHS Trust (Castle Hill Hospital), United Kingdom |
Responsible Party: | Hull & East Yorkshire NHS Trust ( Dr. Jeysen Zivan Yogaratnam ) |
Study ID Numbers: | R0047, 04/Q1104/26 |
Study First Received: | February 14, 2008 |
Last Updated: | February 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00623142 |
Health Authority: | United Kingdom: Medicines and Healthcare Products Regulatory Agency |
Myocardial protection Ischemic Reperfusion Injury Hyperbaric Oxygen Preconditioning |
Heart Diseases Postoperative Complications Myocardial Ischemia Vascular Diseases |
Ischemia Cardiomyopathies Myocardial Reperfusion Injury Reperfusion Injury |
Pathologic Processes Cardiovascular Diseases |